The Cooper Companies, Inc.

COO

US2166485019

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 02:29:43 2024-04-19 pm EDT			5-day change	1st Jan Change
90.74 ^USD	+0.37%		-3.04%	-4.15%

Apr. 03	Citigroup Raises Price Target on Cooper Companies to $116 From $108, Keeps Buy Rating	MT
Mar. 21	Cooper Companies Insider Sold Shares Worth $5,521,230, According to a Recent SEC Filing	MT

The Cooper Companies, Inc.(NYSE:COO) dropped from Russell Midcap Growth Index

June 25, 2021 at 12:00 am EDT

Latest news about The Cooper Companies, Inc.

Citigroup Raises Price Target on Cooper Companies to $116 From $108, Keeps Buy Rating	Apr. 03	MT
Cooper Companies Insider Sold Shares Worth $5,521,230, According to a Recent SEC Filing	Mar. 21	MT
North American Morning Briefing : Markets on Hold -2-	Mar. 20	DJ
All eyes on the Fed	Mar. 19
ANALYST RECOMMENDATIONS : 3M Company, Snowflake, Splunk, Micron, Nvidia...	Mar. 19
Redburn Atlantic Upgrades Cooper Companies to Buy From Neutral, Adjusts Price Target to $125 From $93.75	Mar. 19	MT
Not a care in the world	Mar. 13
JPMorgan Upgrades Cooper Companies to Overweight From Neutral, Adjusts Price Target to $120 From $100	Mar. 13	MT
ANALYST RECOMMENDATIONS : Broadcom, Tesla, Walmart, Entain, Virgin Money UK	Mar. 13
Cooper Companies Insider Sold Shares Worth $24,659,342, According to a Recent SEC Filing	Mar. 11	MT
Piper Sandler Adjusts Price Target on Cooper to $115 From $110, Maintains Overweight Rating	Mar. 01	MT
Cooper to Benefit From Strong Contacts Market as Demand Continues, Morgan Stanley Says	Mar. 01	MT
Mizuho Adjusts Price Target on Cooper to $115 From $102.50, Maintains Buy Rating	Mar. 01	MT
Morgan Stanley Lifts Price Target on Cooper Cos. to $95 From $88.75 After Better-Than-Expected Fiscal Q1; Equalweight Kept	Mar. 01	MT
Cooper Companies lifts annual revenue forecast on strong contact lens demand	Feb. 29	RE
Transcript : The Cooper Companies, Inc., Q1 2024 Earnings Call, Feb 29, 2024	Feb. 29
Cooper Fiscal Q1 Non-GAAP EPS, Net Sales Increase; Issues Outlook	Feb. 29	MT
The Cooper Companies, Inc. Raises its Revenue Guidance for the Fiscal Year 2024	Feb. 29	CI
The Cooper Companies, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	Feb. 29	CI
Cooper Companies Guides For FY 2024 EPS of $3.50-$3.58 on Revenue of $3.847-$3.897 Billion, vs CIQ Analyst Consensus of $3.46/Share on Revenue of $3.86 Billion	Feb. 29	MT
Earnings Flash (COO) COOPERCOMPANIES Posts Q1 Revenue $931.6M, vs. Street Est of $917.5M	Feb. 29	MT
Earnings Flash (COO) COOPERCOMPANIES Reports Q1 EPS $0.85, vs. Street Est of $0.78	Feb. 29	MT
Just as expected	Feb. 29
ANALYST RECOMMENDATIONS : Amex, Snowflake, Salesforce, Walmart, Nutrien...	Feb. 29
The calm after the storm	Feb. 28

Chart The Cooper Companies, Inc.

Duration

Period

More charts

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-30 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for The Cooper Companies, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

90.41 USD

Average target price

107.9 USD

Spread / Average Target

+19.35%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
THE COOPER COMPANIES, INC.	-4.15%	17.97B
ALCON INC.	+10.42%	39.04B
AUTEK CHINA INC.	-25.69%	2.12B
WARBY PARKER INC.	-14.11%	1.4B
PEGAVISION CORPORATION	+14.75%	1.12B
MENICON CO., LTD.	-37.89%	731M
MINGYUE OPTICAL LENS CO.,LTD.	-38.39%	724M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-11.01%	667M
VIZIONFOCUS INC.	+15.96%	491M
VISCO VISION INC.	+7.14%	480M

Glasses, Spectacles & Contact Lenses